European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study.

Autor: Preisser F; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany., Abrams-Pompe RS; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Stelwagen PJ; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Böhmer D; Department of Radiation Oncology, Charité University Hospital, Berlin, Germany., Zattoni F; Department of Surgery, Oncology and Gastroenterology, Urology Clinic, University of Padova, Padova, Italy., Magli A; Department of Radiation Oncology, University Hospital of Udine, ASUIUD, Udine, Italy; Department of Radiation Oncology, Hospital San Martino, Belluno, Italy., Rivas JG; Department of Urology, Clinico San Carlos Hospital, Madrid, Spain., Dilme RV; Department of Urology, Clinico San Carlos Hospital, Madrid, Spain., Sepulcri M; Radiation Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy., Eguibar A; Department of Urology, La Paz University Hospital, Madrid, Spain., Heidegger I; Department of Urology, Medical University Innsbruck, Innsbruck, Austria., Arnold C; Department of Therapeutic Radiology and Oncology, Medical University Innsbruck, Innsbruck, Austria., Fankhauser CD; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland; Department of Urology, University Zurich, Zurich, Switzerland., Chun FK; Department of Urology, University Hospital Frankfurt, Frankfurt, Germany., van der Poel H; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Gandaglia G; Department of Urology, Urological Research Institute, Vita-Salute University and San Raffaele Hospital, Milan, Italy., Wiegel T; Department of Radiotherapy and Radiooncology, University Hospital Ulm, Ulm, Germany., van den Bergh RCN; Department of Urology, Antonius Hospital, Utrecht, The Netherlands., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey. Electronic address: d.tilki@uke.de.

Publikováno v: European urology [Eur Urol] 2024 Feb; Vol. 85 (2), pp. 164-170. Date of Electronic Publication: 2023 Jun 22.

MRI-prostaat voorafgaand aan het eerste consult: efficiënt? Of niet geïndiceerd?

Autor: Maas, Daniel C.^1,2 (AUTHOR) d.maas@hagaziekenhuis.nl, Buddingh, K. Tim^1,2 (AUTHOR), Oldenburg, Philip^2,3 (AUTHOR), de Walle, Steven F.^2,3 (AUTHOR), Wolterbeek, Derek W.^1,2 (AUTHOR), de Vries, Remco R.^2,3 (AUTHOR)

Publikováno v: Tijdschrift voor Urologie. Aug2024, Vol. 14 Issue 5, p105-109. 5p.

Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis.

Autor: Matsukawa A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Fazekas T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Semmelweis University, Budapest, Hungary.; Centre for Translational Medicine, Semmelweis University, Budapest, Hungary., Miszczyk M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Collegium Medicum - Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland., Tsuboi I; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Faculty of Medicine, Shimane University, Shimane, Japan., Kardoust Parizi M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran., Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia., Klemm J; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Mancon S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy., Mori K; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Kimura S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Miki J; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Gomez Rivas J; Department of Urology, Clinico San Carlos Hospital, Madrid, Spain., Soeterik TFW; Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands.; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Zilli T; Department of Radiation Oncology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Tilki D; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, Koc University Hospital, Istanbul, Turkey., Joniau S; Department of Urology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and regeneration, KU Leuven, Leuven, Belgium., Kimura T; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan., Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Semmelweis University, Budapest, Hungary. shahrokh.shariat@meduniwien.ac.at.; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Weill Cornell Medical College, New York, NY, USA. shahrokh.shariat@meduniwien.ac.at.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czechia. shahrokh.shariat@meduniwien.ac.at.; Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan. shahrokh.shariat@meduniwien.ac.at.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.; Research Center for Evidence Medicine, Urology Department, Tabriz University of Medical Sciences, Tabriz, Iran. shahrokh.shariat@meduniwien.ac.at., Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Medical University of Silesia, Zabrze, Poland.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.

Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer.

Autor: Rius Bilbao L; Department of Urology, Barrualde-Galdakao Integrated Health Organisation, Osakidetza Basque Health Service, Calle Itsasondo 10, 3B 48993, Getxo Bizkaia, Spain. leire.rius.bilbao@gmail.com.; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain. leire.rius.bilbao@gmail.com., Aguirre Larracoechea U; Research Unit, Barrualde-Galdakao Integrated Health Organisation, Osakidetza Basque Health Service, Galdakao, Spain.; Kronikgune Institute for Health Services Research, Barakaldo, Spain.; Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Galdakao, Spain., Valladares Gomez C; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Clinical Laboratory Medicine, Ezkerraldea-Enkarterri-Cruces Integrated Health Organisation, Osakidetza Basque Health Service, Barakaldo, Spain., Remmers S; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Mar Medina C; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Clinical Laboratory Medicine, Barrualde-Galdakao Integrated Health Organisation, Osakidetza Basque Health Service, Galdakao, Spain.

Publikováno v: World journal of urology [World J Urol] 2024 Mar 13; Vol. 42 (1), pp. 141. Date of Electronic Publication: 2024 Mar 13.